Suppr超能文献

糖尿病患者血糖水平监测的血糖达标时间专家共识建议:印度视角

Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective.

作者信息

Mohan Viswanathan, Joshi Shashank, Mithal Ambrish, Kesavadev Jothydev, Unnikrishnan Ambika G, Saboo Banshi, Kumar Prasanna, Chawla Manoj, Bhograj Abhijit, Kovil Rajiv

机构信息

Dr. Mohan's Diabetes Specialities Centre, Chennai, India.

Department of Endocrinology, Lilavati Hospital, Mumbai, India.

出版信息

Diabetes Ther. 2023 Feb;14(2):237-249. doi: 10.1007/s13300-022-01355-4. Epub 2023 Jan 27.

Abstract

Keeping up with the global scenario, diabetes prevalence is on rise in India. Inadequate glycemic control is a major cause of diabetes-related morbidity and mortality. The conventional standards of care (SOC) in diabetes, including self-monitoring of blood glucose and measurement of glycated hemoglobin, have supported achievement of glycemic control, yet there are a few limitations. With the use of current technologies and metrics, such as continuous glucose monitoring (CGM) and standardized CGM data reporting, the continuous real-time glucose levels can be measured, and importantly, the percentage of time above, below, and within the target glucose range can be calculated, which facilitates patient-centric care, a current goal in diabetes management. International consensus recommendations endorse the incorporation of CGM and CGM data reporting in SOC for diabetes management. The guidelines provide time in range (TIR) thresholds for different patient populations and different types of diabetes. However, extrapolation of these global guidelines does not aptly cover the Indian population, which has diverse diet, culture, and religious practices. In this context, a consensus meeting was held in India in 2021 with experts in the field of diabetes care. The purpose of the meeting was to develop consensus recommendations for TIR thresholds for different patient profiles in India. Those expert recommendations, together with an evidence-based review, are reported here. The aim of this agreement is to aid clinicians across India to routinely use CGM and CGM data reports for optimizing individualized diabetes care, by implementing clinical targets for TIR.

摘要

紧跟全球形势,印度的糖尿病患病率正在上升。血糖控制不佳是糖尿病相关发病和死亡的主要原因。糖尿病的传统护理标准(SOC),包括血糖自我监测和糖化血红蛋白测量,有助于实现血糖控制,但仍存在一些局限性。通过使用当前技术和指标,如连续血糖监测(CGM)和标准化的CGM数据报告,可以测量连续实时血糖水平,重要的是,可以计算出血糖高于、低于和在目标范围内的时间百分比,这有助于以患者为中心的护理,这是目前糖尿病管理的目标。国际共识建议认可将CGM和CGM数据报告纳入糖尿病管理的SOC中。这些指南为不同患者群体和不同类型的糖尿病提供了血糖在目标范围内时间(TIR)阈值。然而,这些全球指南的外推并不能恰当地涵盖印度人群,因为印度人群的饮食、文化和宗教习俗各不相同。在此背景下,2021年在印度召开了一次糖尿病护理领域专家共识会议。会议的目的是为印度不同患者群体制定TIR阈值的共识建议。此处报告了这些专家建议以及基于证据的综述。本共识的目的是帮助印度各地的临床医生通过实施TIR临床目标,常规使用CGM和CGM数据报告来优化个性化糖尿病护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a418/9943834/6c5b5bfe8a92/13300_2022_1355_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验